UroToday
Contact
Login
Sign Up Free
Menu
Follow UroToday
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Sumanta Kumar Pal, MD
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Daniel George, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mCRPC Treatment
Charles Ryan, MD
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Neal Shore, MD, FACS
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Reference Centers
Urinary Catheters
Indwelling Catheters
Intermittent Catheters
Videos
Conference Coverage and Experts Group
Interviews with Experts at Conferences
ASCO 2019
ASCO GU 2019
ESMO 2018
ESMO 2019
Exclusive Collaborations
APCCC 2019
LUGPA 2018
PCF 2018
PCF 2019
SNMMI Curriculum
UroToday Exclusives
Book Club
Urologic Oncology
Bladder Cancer
Bladder Cancer
Advanced Bladder Cancer
Bladder Cancer Special Session EAU 2019
Kidney Cancer
Advanced Kidney Cancer
Renal Cancer
Prostate Cancer
Active Surveillance: Prostate Cancer
Advanced Prostate Cancer
CRPC with Bone Metastases
Imaging: Prostate Cancer
Localized Prostate Cancer
mCRPC
mHSPC
Molecular Diagnostics
Navigating Cancer
nmCRPC
Precision Medicine in Prostate Cancer
Prostate Cancer
Upper Tract Urothelial Tumors
Upper Tract Urothelial Carcinoma
Pelvic Health & Reconstruction
Bladder Health
Indwelling Catheters
Intermittent Catheters
Nocturia & Lower Urinary Tract Conditions
Endourology
Endourology Today
Endourology
Journals
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology - Oncology Insights
Prostate Cancer and Prostatic Diseases
Clinical Trials
Clinical Trials
Search Clinical Trials
From the Editor
Current Letter
Previous Letters
Conference Coverage
Advanced Prostate Cancer Consensus Conference (APCCC)
2019 Biennial Meeting
American Society of Clinical Oncology (ASCO)
2019 Annual Meeting
2019 ASCO GU Symposium
2018 Annual Meeting
2018 ASCO GU Symposium
2017 Annual Meeting
American Urological Association (AUA)
2019 Annual Meeting
2018 Northeastern Section
2018 Annual Meeting
2017 Quality Improvement Summit
2017 Annual Meeting
Bladder Cancer Advocacy Network (BCAN)
2019 Think Tank
Canadian Urological Association (CUA)
2019 CUOS Summit
2018 Annual Meeting
2017 Annual Meeting
Clinical Conference
2019 American College of Surgeons
2018 American College of Surgeons
European Association of Urology (EAU)
2019 Annual Congress
ESOU 2019
2018 Annual Congress
ERUS 2018
ESOU 2018
PCa 2018
Enhanced Recovery After Surgery (ERAS)
2019 ERAS Annual Congress
European Society for Medical Oncology (ESMO)
2019 Annual Congress
2018 Annual Congress
2017 Annual Congress
International Bladder Cancer Network (IBCN)
2019 Meeting
2018 Meeting
International Continence Society (ICS)
2018 Meeting
Mexican Association of Oncological Urology
2018 Annual Meeting
Société Internationale d'Urologie (SIU)
2019 Annual Congress
2018 Annual Congress
2017 Annual Congress
Society of Nuclear Medicine and Molecular Imaging (SNMMI)
2019 Therapeutics Conference
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
2019 Congress
2018 Congress
Society of Urologic Oncology (SUO)
2019 Annual Meeting
2018 Annual Meeting
2017 Annual Meeting
Targeted Alpha Therapy (TAT)
2019 Symposium
2017 Symposium
World Congress of Endourology and SWL (WCE)
2019 Annual Meeting
2018 Annual Meeting
2017 Annual Meeting
Articles
Urologic Oncology
Adrenal Diseases
Bladder Cancer
CRPC w/ Bone Metastases
Penile Cancer
Prostate Cancer
Renal Cancer
Testicular Cancer
Upper Tract Tumors
Investigative Urology
Men's Health
Androgen Deficiency
BPH
Erectile Dysfunction
Male Infertility
Peyronie’s Disease
Prostatitis
Vasectomy
Pelvic Health & Reconstruction
Fecal Incontinence
Fistula
GU Trauma & Reconstruction
Indwelling Catheters
Infections
Intermittent Catheters
Interstitial Cystitis
Neurogenic Bladder
Nocturia
Overactive Bladder
Pelvic Prolapse
Post-prostatectomy Incontinence
Stress Incontinence
Underactive Bladder
Urethral Strictures
Urinary Incontinence
Urinary Retention
Urinary Tract Infection – CAUTIs
Urologic Catheters
Endourology & Urolithiasis
Minimally Invasive Procedures
Stone Disease
Pediatric Urology
Pediatric Urology
Calendar
UroToday Home
Tags
High-risk Localized Prostate Cancer Articles
Articles
Enter Part of Title
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy: Beyond the Abstract
High-risk localized prostate cancer is a highly heterogeneous disease from a clinical and biological standpoint. It carries a significant chance of morbidity and mortality. The 2015 National Comprehensive Cancer Network (NCCN) guidelines define high-risk prostate cancer as a biopsy Gleason score of 8–10, a PSA level greater than 20 ng/mL, or clinical stage T3a disease. Despite the impact of PSA screening on improves outcome of men with prostate cancer, a significant proportion of men continue to present with high risk disease and need optimal treatment.
Published August 15, 2017
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
BACKGROUND:
In advanced prostate cancer (APC), successful drug development as well as advances in imaging and molecular characterisation have resulted in multiple areas where there is lack of evidence or low level of evidence. The Advanced Prostate Cancer Consensus Conference (APCCC) 2017 addressed some of these topics.
Published July 5, 2017
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free